Self-assembly of carbon nanotubes and antibodies on tumours for targeted amplified delivery

Single-walled carbon nanotubes can target tumours in a two-step approach in which nanotubes modified with morpholino oligonucleotide sequences bind to cancer cells that have been pre-targeted with antibodies modified with oligonucleotide strands complementary to those on the nanotubes.